To Evaluate the Effect of Inhaled Medication Together With Exercise and Activity Training on Exercise Capacity and Daily Activities in Patients With Chronic Lung Disease With Obstruction of Airways

NCT02085161 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

304

Enrollment

INDUSTRY

Sponsor class

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG: placebo to tiotropium + olodaterol
DRUG: tiotropium+olodaterol
DRUG: tiotropium +olodaterol
DRUG: tiotropium

Sponsor

Boehringer Ingelheim